NASDAQ · Biotechnology

LQDA (LQDA) Stock

$84.15 -0.33% NASDAQ: LQDA Healthcare

Valuation

MetricValue
Price$84.15
Market Cap$7.48B
P/E Ratio332.94
P/B Ratio110.33
P/S Ratio17.57
EPS (TTM)$-0.80
52-Week High$89.50
52-Week Low$11.85
Dividend Yield—

Financials & Margins

MetricValue
ROE28.18%
ROA9.05%
ROCE-113.33%
Gross Margin98.72%
Operating Margin15.81%
Net Margin7.74%
Debt/Equity1.70
Current Ratio2.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$16.0M$17.0M$14.0M$158.0M
Operating Profit$-34.0M$-39.0M$-73.0M$-121.0M$-51.0M
Net Profit$-35.0M$-41.0M$-79.0M$-128.0M$-69.0M
EPS$-0.70$-0.67$-1.21$-1.63$-0.80
Op Margin-263.0%-243.0%-420.0%-867.0%-32.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$94.0M$129.0M$118.0M$230.0M$328.0M
Total Liabilities$28.0M$39.0M$71.0M$151.0M$283.0M
Cash$57.0M$93.0M$84.0M$176.0M$191.0M
Borrowings$10.0M$20.0M$20.0M$20.0M$20.0M

Latest News

Here's Why You Should Add INKT Stock to Your Portfolio Now Zacks · Jul 16, 2026 Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance Zacks · Jul 16, 2026 Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal Zacks · Jul 15, 2026 Liquidia Insider Sold Shares Worth $2,520,683, According to a Recent SEC Filing MT Newswires · Jul 15, 2026 Liquidia Insider Sold Shares Worth $1,460,965, According to a Recent SEC Filing MT Newswires · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-29.0M$-42.0M$-93.0M$-36.0M
Investing Cash Flow$0$-1.0M$-11.0M$-8.0M$-6.0M
Financing Cash Flow$26.0M$65.0M$43.0M$195.0M$60.0M
Net Cash Flow$-8.0M$36.0M$-10.0M$93.0M$18.0M
Free Cash Flow$-34.0M$-29.0M$-43.0M$-98.0M$-40.0M

Valuation & Return Ratios

MetricValue
PEG Ratio7.22
EV / EBITDA107.14
FCF Yield-0.80%
Quick Ratio1.98
Interest Coverage-8.50
Return 1Y435.70%
Return 3Y892.52%
Return 5Y3072.16%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About LQDA

LQDA is led by CEO Roger A. Jeffs, employs 216 people, headquartered in Morrisville, US, publicly traded since 2018.

LQDA stock trades at $84.15 with a market capitalization of $7.48B. The stock is valued at a price-to-earnings (P/E) ratio of 332.94, price-to-book of 110.33, price-to-sales of 17.57. Over the past 52 weeks the stock has ranged between $11.85 and $89.50, and currently trades 6.0% below its 52-week high.

On profitability, LQDA generates a return on equity (ROE) of 28.18% — well above the market average, a sign of a high-quality business, return on capital employed of -113.33%, an operating margin of 15.81%, a net profit margin of 7.74%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides